Detalhe da pesquisa
1.
Efficacy of immunotherapy with TG4040, peg-interferon, and ribavirin in a Phase 2 study of patients with chronic HCV infection.
Gastroenterology
; 147(1): 119-131.e3, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24657484
2.
In routine clinical practice, few physicians use early viral kinetics to guide HCV dual therapy treatment decisions.
Liver Int
; 34(7): e217-28, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24251988
3.
SVR24 rates in patients with HCV genotype 5 and 6 infection treated with peginterferon alfa-2a (40KD) plus ribavirin: results from the real world PROPHESYS study.
Ann Hepatol
; 13(2): 303-4, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24558225
4.
Chronic hepatitis B monitoring and treatment patterns in five European countries with different access and reimbursement policies.
Antivir Ther
; 19(3): 245-57, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24343051